2011年的结束,标志着发生一系列改变我们对药物安全认识事件的五十周年的到来。FDA的谨慎在半个世纪之前,美国FDA并没有权力要求制药厂家生产的药物必须达到相关疗效标准,或者向公众披露一种新药有合理的治疗益处-风险关系;药物 The year 2011 marks the fiftieth anniversary of a series of events that have changed our understanding of drug safety. FDA cautious Half a century ago, the U.S. FDA did not have the authority to require pharmaceutical manufacturers to meet the relevant standards of efficacy or to disclose to the public a reasonable therapeutic benefit of a new drug-risk relationship; the drug